University of Michigan IRB — Ann Arbor, Michigan

University of Michigan IRB is a clinical research site located in Ann Arbor, Michigan, United States 48109-2800.

Crixeo Health Trust Score: 44/100 (POOR). This profile has not yet been claimed by the site owner.

University of Michigan IRB has participated in 1 clinical trials.

Therapeutic areas: Acute Lymphoblastic Leukemia (ALL), Diffuse Large B-cell Lymphoma (DLBCL).

Sponsors: Novartis Pharmaceuticals.

Sponsor Feasibility Report

Trust Score: 44/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for University of Michigan IRB?

University of Michigan IRB has a Crixeo Trust Score of 44/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has University of Michigan IRB conducted?

University of Michigan IRB has 1 clinical trials on record. Their work covers Acute Lymphoblastic Leukemia (ALL), Diffuse Large B-cell Lymphoma (DLBCL).

Is University of Michigan IRB accredited by Crixeo Health?

University of Michigan IRB has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about University of Michigan IRB?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.